FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

270,995 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 117
R2B: 0
R3: 21,787
R4: 158,444
R4B: 43,719
R5: 32,499
R6: 2,222

By Authority

none: 189,580
hl7: 74,857
ihe: 1,324
national: 3,888
who: 1,346

By Realm

none: 183,568
au: 736
be: 606
br: 400
ca: 1,464
ch: 1,776
cl: 564
cr: 117
cz: 862
de: 2,090
dk: 1,497
ee: 260
eu: 967
fi: 87
fr: 3,334
il: 328
in: 163
it: 116
jp: 174
kr: 30
nl: 2,247
no: 125
nz: 240
pl: 258
pt: 50
se: 161
stt: 116
tw: 1,414
uk: 6
us: 23,032
uv: 44,063
vn: 108
other: 6

Start Prev Rows 226800 - 227000 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1003.json	Malignant Neoplasm of Colon	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1025.json	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1027.json	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1044.json	Pap Test	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1047.json	Mammography	active	2024-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1051.json	Colonoscopy	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1052.json	Colonoscopy	active	2017-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1053.json	Colonoscopy	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1145.json	sDNA FIT Test	active	2017-12	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1001.json	Malignant Neoplasm of Colon	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1009.json	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1017.json	Pap Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1018.json	Mammography	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1020.json	Colonoscopy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1038.json	CT Colonography	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1039.json	sDNA FIT Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1024.json	Kidney Transplant	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1025.json	Kidney Transplant	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1026.json	Dialysis Services	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1027.json	Dialysis Services	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1028.json	Dialysis Services	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1029.json	ESRD Monthly Outpatient Services	active	2017-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1052.json	Kidney Transplant	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1060.json	Kidney Transplant Recipient	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1067.json	Kidney Transplant	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1012.json	Kidney Transplant	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1013.json	Dialysis Services	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1014.json	ESRD Monthly Outpatient Services	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1029.json	Kidney Transplant Recipient	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1065.json	DTaP Vaccine Administered	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1066.json	DTaP Vaccine Administered	active	2024-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1068.json	Hepatitis A	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1070.json	Hepatitis A	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1078.json	Measles	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1080.json	Measles	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1085.json	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1086.json	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1087.json	Mumps	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1089.json	Mumps	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1098.json	Rubella	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.110.json	Rubella	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1104.json	Varicella Zoster	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1105.json	Varicella Zoster	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1106.json	Varicella Zoster Vaccine (VZV) Administered	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1107.json	Varicella Zoster Vaccine (VZV) Administered	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1109.json	Hepatitis A Vaccine Administered	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1110.json	Hepatitis A Vaccine Administered	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1111.json	Hepatitis B Vaccine Administered	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1112.json	Hepatitis B Vaccine Administered	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1115.json	Child Influenza Vaccine Administered	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1116.json	Child Influenza Vaccine Administered	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1117.json	Inactivated Polio Vaccine (IPV) Administered	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1118.json	Inactivated Polio Vaccine (IPV) Administered	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1119.json	Pneumococcal Conjugate Vaccine Administered	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1120.json	Rotavirus Vaccine (3 dose schedule) Administered	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1121.json	Rotavirus Vaccine (2 dose schedule) Administered	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1123.json	Genital Herpes	active	2024-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1124.json	Genital Herpes	active	2024-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1128.json	Lab Tests for Sexually Transmitted Infections	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1129.json	Chlamydia Screening	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1133.json	Pneumococcal Conjugate Vaccine Administered	active	2024-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1135.json	HPV Test	active	2024-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1148.json	Rotavirus Vaccine (2 Dose Schedule) Administered	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1149.json	Rotavirus Vaccine (3 Dose Schedule) Administered	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1150.json	Advanced Illness	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1151.json	Advanced Illness	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1152.json	HiB Vaccine (3 dose schedule)	active	2021-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1153.json	HiB Vaccine (3 dose schedule) Administered	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1154.json	HiB Vaccine (4 dose schedule)	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1155.json	HiB Vaccine (4 dose schedule) Administered	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1156.json	HiB Vaccine (3 dose schedule) Administered	active	2024-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1157.json	HiB Vaccine (4 dose schedule) Administered	active	2024-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1158.json	Competing Conditions for Respiratory Conditions	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1159.json	Competing Conditions for Respiratory Conditions	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1022.json	DTaP Vaccine Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1024.json	Hepatitis A	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1031.json	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1032.json	Mumps	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1037.json	Rubella	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1039.json	Varicella Zoster	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1040.json	Varicella Zoster Vaccine (VZV) Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1041.json	Hepatitis A Vaccine Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1042.json	Hepatitis B Vaccine Administered	active	2022-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1044.json	Child Influenza Vaccine Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1045.json	Inactivated Polio Vaccine (IPV) Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1046.json	Pneumococcal Conjugate Vaccine Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1047.json	Rotavirus Vaccine (3 dose schedule) Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1048.json	Rotavirus Vaccine (2 dose schedule) Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1049.json	Genital Herpes	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1051.json	Lab Tests for Sexually Transmitted Infections	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1052.json	Chlamydia Screening	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1053.json	Measles	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1059.json	HPV Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1082.json	Advanced Illness	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1083.json	Hib Vaccine (3 dose schedule)	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1084.json	Hib Vaccine (3 dose schedule) Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1085.json	Hib Vaccine (4 dose schedule)	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1086.json	Hib Vaccine (4 dose schedule) Administered	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1087.json	Influenza Virus LAIV Vaccine	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1088.json	Influenza Virus LAIV Vaccine Administered	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1012.json	Lab Tests During Pregnancy	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1013.json	Diagnostic Studies During Pregnancy	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1019.json	Pregnancy Test	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1022.json	Complications of Pregnancy, Childbirth and the Puerperium	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1023.json	Complications of Pregnancy, Childbirth and the Puerperium	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1028.json	Procedures for Sexual Activity	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1030.json	Procedures for Sexual Activity	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1031.json	Diagnosis for Sexual Activity	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1032.json	Diagnosis for Sexual Activity	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1033.json	Procedures for Sexual Activity	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1007.json	Lab Tests During Pregnancy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1008.json	Diagnostic Studies During Pregnancy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1011.json	Pregnancy Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1012.json	Complications of Pregnancy, Childbirth and the Puerperium	active	2022-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1016.json	Congenital or Acquired Absence of Cervix	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1017.json	Procedures Used to Indicate Sexual Activity	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1018.json	Diagnoses Used to Indicate Sexual Activity	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1024.json	Absence of Cervix	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1025.json	Absence of Cervix	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1026.json	Absence of Cervix	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1073.json	Osteoporosis Without Current Fracture	active	2017-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1074.json	Osteoporosis Without Current Fracture	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1200.json	Osteoporosis With Current Fracture	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1201.json	Osteoporosis With Current Fracture	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1202.json	DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1308.json	Frailty Diagnosis	active	2024-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1309.json	Frailty Diagnosis	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1310.json	Frailty Symptom	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1311.json	Frailty Symptom	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1038.json	Osteoporosis Without Current Fracture	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1050.json	Osteoporosis With Current Fracture	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1051.json	DXA (Dual energy Xray Absorptiometry) Scan	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1074.json	Frailty Diagnosis	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1075.json	Frailty Symptom	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1021.json	Narcolepsy	active	2018-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1023.json	Narcolepsy	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1024.json	Neurologic impairment	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1025.json	Neurologic impairment	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1026.json	Neurologic impairment	active	2021-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.12.1011.json	Narcolepsy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.12.1012.json	Neurologic impairment	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1149.json	Substance Use Disorder Long Acting Medication	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.115.11.1248.json	Retinal or Dilated Eye Exam	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.115.12.1088.json	Retinal or Dilated Eye Exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1150.json	Substance Use Disorder Short Acting Medication	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1151.json	Substance Use Disorder Long Acting Medication Administration	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1152.json	Substance Use Disorder Short Acting Medication Administration	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1155.json	Substance Use Disorder Short Acting Medication Administration	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1156.json	Substance Use Disorder Long Acting Medication Administration	active	2021-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1157.json	Substance Use Disorder Short Acting Medication Administration	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1163.json	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1164.json	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1165.json	Hospice Diagnosis	active	2022-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1166.json	Hospice Diagnosis	active	2022-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1167.json	Palliative Care Diagnosis	active	2022-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1168.json	Palliative Care Diagnosis	active	2022-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1169.json	Palliative Care Diagnosis	active	2022-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1031.json	Hyperthyroidism	active	2018-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1033.json	Hyperthyroidism	active	2018-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1034.json	Hyperparathyroidism	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1036.json	Hyperparathyroidism	active	2018-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.12.1015.json	Hyperthyroidism	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.12.1016.json	Hyperparathyroidism	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1170.json	Atomoxetine	active	2022-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1171.json	Clonidine	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1172.json	Dexmethylphenidate	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1173.json	Dextroamphetamine	active	2022-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1174.json	Lisdexamfetamine	active	2022-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1176.json	Methylphenidate	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1177.json	Lower Body Fractures Excluding Ankle and Foot	active	2022-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1178.json	Lower Body Fractures Excluding Ankle and Foot	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1179.json	Malignant Neoplasms of Lower and Unspecified Limbs	active	2022-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1042.json	Counseling for Physical Activity	active	2019-03	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1077.json	Falls Screening	active	2018-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1097.json	CT Colonography	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1220.json	Frailty Device SNOMED	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.12.1028.json	Falls Screening	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.12.1035.json	Counseling for Physical Activity	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.12.1300.json	Frailty Device	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1180.json	Malignant Neoplasms of Lower and Unspecified Limbs	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1181.json	Mechanical Complications Excluding Upper Body	active	2022-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1182.json	Mechanical Complications Excluding Upper Body	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1183.json	Partial Arthroplasty of Hip	active	2022-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1184.json	Partial Arthroplasty of Hip	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1188.json	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2022-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1189.json	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1190.json	Antibiotic Medications for Upper Respiratory Infection	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1193.json	Malignant Neoplasms	active	2022-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1194.json	Malignant Neoplasms	active	2022-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1196.json	Atherosclerosis of the Extremities	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1197.json	Atherosclerosis of the Extremities	active	2023-07	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1198.json	Atherosclerosis of the Extremities	active	2023-07	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1199.json	Lower Extremity Neurological Assessment Result or Finding	active	2023-07	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1001.json	Disorders of the Immune System	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1003.json	Disorders of the Immune System	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1004.json	HIV Viral Load	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1008.json	HIV 2	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1010.json	HIV 2	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1011.json	Severe Combined Immunodeficiency	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1012.json	Severe Combined Immunodeficiency	active	2023-02	us	hl7	1